MARK3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.891820E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.854410E-01
Normal-vs-Stage2
1.864400E-01
Normal-vs-Stage3
4.659400E-01
Normal-vs-Stage4
3.086200E-01
Stage1-vs-Stage2
5.819200E-01
Stage1-vs-Stage3
9.941200E-01
Stage1-vs-Stage4
8.806400E-01
Stage2-vs-Stage3
8.222000E-01
Stage2-vs-Stage4
7.597200E-01
Stage3-vs-Stage4
9.475200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.182800E-01
Normal-vs-AfricanAmerican
1.725760E-01
Normal-vs-Asian
1.271570E-01
Caucasian-vs-AfricanAmerican
2.098200E-01
Caucasian-vs-Asian
1.973640E-01
AfricanAmerican-vs-Asian
8.123000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.793020E-01
Normal-vs-Female
2.233800E-01
Male-vs-Female
7.435400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.866400E-01
Normal-vs-Age(41-60Yrs)
3.250000E-01
Normal-vs-Age(61-80Yrs)
1.729650E-01
Normal-vs-Age(81-100Yrs)
3.734600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.205400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.844600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.084200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.422100E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.438500E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.556800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.424100E-02
Normal-vs-Daily Drinker
2.193000E-01
Normal-vs-Weekly Drinker
6.923200E-01
Normal-vs-Occasional Drinker
4.819400E-01
Normal-vs-Social Drinker
2.058800E-01
Non Drinker-vs-Daily Drinker
2.444600E-01
Non Drinker-vs-Weekly Drinker
1.434630E-01
Non Drinker-vs-Occasional Drinker
1.427650E-02
Non Drinker-vs-Social Drinker
1.538550E-01
Daily Drinker-vs-Weekly Drinker
4.209000E-01
Daily Drinker-vs-Occasional Drinker
2.166000E-01
Daily Drinker-vs-Social Drinker
7.821000E-01
Weekly Drinker-vs-Occasional Drinker
9.700200E-01
Weekly Drinker-vs-Social Drinker
5.193800E-01
Occasional Drinker-vs-Social Drinker
3.190400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.718400E-01
Normal-vs-Grade 2
9.520200E-01
Normal-vs-Grade 3
9.607200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.753800E-01
Grade 1-vs-Grade 3
8.450400E-01
Grade 1-vs-Grade 4
9.718400E-01
Grade 2-vs-Grade 3
8.095200E-01
Grade 2-vs-Grade 4
9.520200E-01
Grade 3-vs-Grade 4
9.607200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.618760E-01
Normal-vs-NonDiabetic
2.466600E-01
Diabetic-vs-NonDiabetic
5.318600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.204640E-01
Normal-vs-NoPancreatitis
2.079200E-01
Pancreatitis-vs-NoPancreatitis
3.861600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.276170E-01
Normal-vs-N1
2.198000E-01
N0-vs-N1
4.603400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.456200E-01
Normal-vs-TP53-NonMutant
1.573220E-01
TP53-Mutant-vs-TP53-NonMutant
1.315780E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
